NewScen Coast Bio-Pharmaceutical Co., Ltd. (NewScen), headquartered in Tianjin (the biggest port city in Northern China), taking up 1,000 m2 GMP standard factory with 300 employees, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing our customers with professional rapid diagnosis solutions since founded in 2003.

By “Creating an International Brand of Approachable & Reliable Microfluidics Products” as Newscen’s mission, we’ve rededicated to serve all of our customers in pride with a full life cycle covered national health management system.

Through the trust and support of our clients across 90 countries and regions worldwide, our products are continually expanded to approximately 100 kinds in 10 series with comprehensive applications in fields of primary medical care, disease control and prevention, epidemic disease screening, severe acute disease diagnosis, health management, etc.